C07C 311/30
Sulfonamides, the carbon skeleton of the acid part being further substituted by
Official title: Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
C07C311/30 (Sulfonamides, the carbon skeleton of the acid part being further substituted by) appears on 1,065 US grants and 986 published applications in this corpus.
Search patents in C07C- Granted patents
- 1,065
- Published applications
- 986
- Assignees
- 578
- Inventors
- 3,584
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 12 | 0 |
| 1977 | 5 | 0 |
| 1978 | 12 | 0 |
| 1979 | 6 | 0 |
| 1980 | 6 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 7 | 0 |
| 1991 | 8 | 0 |
| 1992 | 13 | 0 |
| 1993 | 14 | 0 |
| 1994 | 14 | 0 |
| 1995 | 18 | 0 |
| 1996 | 25 | 0 |
| 1997 | 27 | 0 |
| 1998 | 37 | 0 |
| 1999 | 32 | 0 |
| 2000 | 37 | 0 |
| 2001 | 35 | 5 |
| 2002 | 51 | 47 |
| 2003 | 50 | 71 |
| 2004 | 34 | 78 |
| 2005 | 41 | 58 |
| 2006 | 32 | 53 |
| 2007 | 40 | 48 |
| 2008 | 35 | 41 |
| 2009 | 36 | 49 |
| 2010 | 23 | 55 |
| 2011 | 30 | 25 |
| 2012 | 40 | 39 |
| 2013 | 34 | 40 |
| 2014 | 37 | 51 |
| 2015 | 34 | 49 |
| 2016 | 24 | 30 |
| 2017 | 34 | 33 |
| 2018 | 22 | 26 |
| 2019 | 23 | 29 |
| 2020 | 25 | 27 |
| 2021 | 25 | 28 |
| 2022 | 14 | 25 |
| 2023 | 14 | 21 |
| 2024 | 15 | 30 |
| 2025 | 13 | 19 |
| 2026 | 17 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 311/37Having the sulfur atom of at least one of the sulfonamide groups617
- C07C 311/45At least one of the singly-bound nitrogen atoms being part of any531
- C07C 311/31Having the sulfur atoms of the sulfonamide groups bound to acyclic carbon102
- C07C 311/36Having the sulfur atom of at least one of the sulfonamide groups6
Recent patents
- Capsaicin analogs and uses thereof29 Sep 2026US 12,747,200 B2Young BioPharma, LLC
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- Arylsulfonamides as orexin receptor agonists8 Sep 2026US 12,729,178 B2Research Triangle Institute
- Methods and compositions for targeting Tregs using CCR8 inhibitors28 Jul 2026US 12,692,239 B2Nanjing Immunophage Biomedical Co., Ltd.
- Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 2830 Jun 2026US 12,668,571 B2Dana-Farber Cancer Institute, Inc.
- Cyclohexyl or heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia17 Sep 2026US 2026/0274785 A1Atrogi AB
- A method of treating seeds and seeds produced thereby13 Aug 2026US 2026/0231848 A1Cyprus University of Technology
- Inhibitors of the ras oncoprotein, methods of making and methods of use thereof13 Aug 2026US 2026/0232689 A1University of Louisville Research Foundation, Inc.
- Process for preparation of sulfamoyl chloride30 Jul 2026US 2026/0217530 A1Firmenich SA
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
Most cited
By later US patents
- Phenyl heterocycles as cox-2 inhibitors281US 5,474,995 AMerck Frosst Canada, Inc. · 1995
- Phenyl heterocycles as cox-2 inhibitors208US 5,550,142 AMerck Frosst Canada, Inc. · 1996
- Phenyl heterocycles as COX-2 inhibitors204US 5,536,752 AMerck Frosst Canada, Inc. · 1996
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Benzamides and related inhibitors of factor Xa155US 7,285,565 B2Millennium Pharmaceuticals, Inc. · 2007